Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
Preferred Name | Liraglutide | |
Synonyms |
|
|
Definitions |
A long-acting, fatty acylated glucagon-like peptide-1 (GLP-1) analog administered subcutaneously, with antihyperglycemic activity. Liraglutide's prolonged action and half-life of 11-15 hours are attributed to the attachment of the fatty acid palmitic acid to GLP-1 that reversibly binds to albumin. Albumin binding protects liraglutide from immediate degradation and elimination and causes GLP-1 to be released from abumin in a slow and consistent manner. This agent may cause thyroid C-cell tumors and increases the risk of acute pancreatitis. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C82239 |
|
CAS_Registry |
204656-20-2
|
|
Chemical_Formula |
C172H265N43O51
|
|
code |
C82239
|
|
Contributing_Source |
CTRP FDA
|
|
definition |
A long-acting, fatty acylated glucagon-like peptide-1 (GLP-1) analog administered subcutaneously, with antihyperglycemic activity. Liraglutide's prolonged action and half-life of 11-15 hours are attributed to the attachment of the fatty acid palmitic acid to GLP-1 that reversibly binds to albumin. Albumin binding protects liraglutide from immediate degradation and elimination and causes GLP-1 to be released from abumin in a slow and consistent manner. This agent may cause thyroid C-cell tumors and increases the risk of acute pancreatitis.
|
|
Display_Name |
Liraglutide
|
|
FDA_UNII_Code |
839I73S42A
|
|
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C176424 |
|
label |
Liraglutide
|
|
Legacy Concept Name |
Liraglutide
|
|
NCI_Drug_Dictionary_ID |
775374
|
|
PDQ_Closed_Trial_Search_ID |
775374
|
|
PDQ_Open_Trial_Search_ID |
775374
|
|
Preferred_Name |
Liraglutide
|
|
prefixIRI |
NCIT:C82239
|
|
prefLabel |
Liraglutide
|
|
Semantic_Type |
Pharmacologic Substance
|
|
UMLS_CUI |
C1456408
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping